Axon Enterprise
AXON
#728
Rank
NZ$59.71 B
Marketcap
NZ$735.10
Share price
-2.10%
Change (1 day)
-40.07%
Change (1 year)

Earnings for Axon Enterprise (AXON)

Earnings in 2026 (TTM): NZ$0.51 Billion

According to Axon Enterprise 's latest financial reports the company's current earnings are NZ$3.21 Billion. In 2025 the company made an earning of NZ$0.20 Billion a decrease over its 2024 earnings that were of NZ$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Axon Enterprise from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.51 B156.82%
2025 NZ$0.20 B-70.87%
2024 NZ$0.69 B147.92%
2023 NZ$0.27 B68.08%
2022 NZ$0.16 B-155.47%
2021 -NZ$0.3 Billion1088.15%
2020 -NZ$25.17 Million121.3%
2019 -NZ$11.38 Million-125.74%
2018 NZ$44.17 M90.75%
2017 NZ$23.16 M-59.11%
2016 NZ$56.64 M-9.86%
2015 NZ$62.83 M8.71%
2014 NZ$57.8 M10.67%
2013 NZ$52.23 M43.35%
2012 NZ$36.43 M-402.97%
2011 -NZ$12.03 Million33.15%
2010 -NZ$9.04 Million6315.17%
2009 -NZ$0.15 Million-100.45%
2008 NZ$31.06 M-14.25%
2007 NZ$36.23 M-474.06%
2006 -NZ$9.69 Million-449.46%
2005 NZ$2.77 M-94.95%
2004 NZ$54.9 M307.28%
2003 NZ$13.48 M1999.86%
2002 NZ$0.64 M-63.88%
2001 NZ$1.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
XBiotech
XBIT
-NZ$79.78 Million-115.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.15 Billion-126.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.84 B 248.82%๐Ÿ‡บ๐Ÿ‡ธ USA